Document ID: chunk:federal_register_of_legislation:F2022N00332:front:0:p1
Version: federal_register_of_legislation:F2022N00332
Segment Type: other
Provision Reference: 
Character Range: 0–3142

PB 133 of 2022
National Health (April 2023 Price Reductions) (Exercise of Ministerial discretion) Determination (No.1) 2022
National Health Act 1953
I, DAVID LAFFAN, Acting First Assistant Secretary, Technology Assessment and Access Division, Department of Health and Aged Care, delegate of the Minister for Health and Aged Care make this determination under subsection 99ACC(5C) and subsection 99ACF(3) of the National Health Act 1953.

Dated        21 December 2022

DAVID LAFFAN
Acting First Assistant Secretary
Technology Assessment and Access Division
Health Resourcing Group
Department of Health and Aged Care

      1    Name of Determination

        (1)   This instrument is the National Health (April 2023 Price Reductions) (Exercise of Ministerial discretion) Determination (No.1) 2022.

        (2)   This instrument may also be cited as PB 133 of 2022.

      2             Commencement

          (1)        Each provision of this instrument specified in column 1 of the table commences, or is taken to have commenced, in accordance with column 2 of the table. Any other statement in column 2 has effect according to its terms.

Commencement information
Column 1                          Column 2                                Column 3
Provisions                        Commencement                            Date/Details
1.  The whole of this instrument  The day this instrument is registered.

               Note: This table relates only to the provisions of this instrument as originally made. It will not be amended to deal with any later amendments of this instrument.

          (2)          Any information in column 3 of the table is not part of this instrument. Information may be inserted in this column, or information in it may be edited, in any published version of this instrument.

      3             Definition

                       Note: A number of expressions used in this instrument are defined in Part VII the Act.

      In this instrument:

         Act means the National Health Act 1953.

       catch-up price reduction day has the same meaning as in subsection 99ACN(6) of the Act.

      4             Authority

      This instrument is made under subsection 99ACC(5C) and subsection 99ACF(3) of the Act.

      5 Brand of pharmaceutical item (combination item) not subject to a price reduction

  I determine, under paragraph 99ACC(5C)(a) of the Act, that the approved ex-manufacturer price, and each of the claimed prices (if applicable) of each single brand of combination item specified in column 2 as an item in the table in Schedule 1 is not reduced under subsection 99ACC(2) or subsection 99ACC(5) of the Act, as appropriate, in relation to the reduction day.

      6 Brand of pharmaceutical item not subject to a price reduction

  I determine, under paragraph 99ACF(3)(a) of the Act, that the approved ex-manufacturer price, and each of the claimed prices (if applicable) of each brand of pharmaceutical item specified in column 2 as an item in the table in Schedule 2 is not reduced under a provision mentioned in item 2A or item 3A or item 4A or